Skip to main content
OpenTrials
Completed

NCT Number: NCT02918214

Prognostic Assessment of Diastolic and Systolic Left Ventricular Function in Septic Shock

Sepsis induces a reversible systolic and diastolic cardiac dysfunction. The presence of a left ventricular (LV) diastolic dysfunction during septic shock could favor harmful volume overload. Recently, a meta-analysis suggested a negative prognostic role of LV diastolic dysfunction in septic patients (Od Ratio: 1.82; 95%CI: 1.12 - 2.97; p = 0.02) but its external validity is hampered by the numerous limits and the heterogeneity of the studies. To date, a pathophysiological link between LV diastolic dysfunction associated with septic shock and the water balance (reflecting volume overload) remains to establish. In addition, small size studies reported an excess of mortality in patients with septic shock who were diagnosed with a high cardiac output. However, no large cohort has yet confirmed the negative prognostic role of a hyperkinetic hemodynamic profile at the initial phase of septic shock.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital, Amiens, France

Loading trial locations.

About this study

Consecutive patients diagnosed with septic shock will be followed daily using echocardiography from Day1 (first echocardiography performed within 12h after the diagnosis of septic shock) to Day3, after vasopressor discontinuation (Day end), and on Day28 or at hospital discharge (if occurs before Day28). Echocardiographic data will be anonymized and stored in DICOM format in a dedicated database for independent measurements by an expert in echocardiography blinded from the clinical data of the patients including vital status. Vital and biological parameters usually monitored for the management of septic shock will be collected at the time of each echocardiographic assessment. Patients' vital status will be collected on Day28. The potential influence of LV diastolic dysfunction and LV hyperkinesia on prognosis will be assessed.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient hospitalized in ICU for septic shock:
  • Documented or highly suspected infection (clinically or microbiologically)
  • Causing an organ failure defined as an acute change in total SOFA score ≥ 2 points (baseline SOFA score can be assumed to be zero in the absence of pre-existing organ dysfunction)
  • And low blood pressure (sBP < 90 mmHg or a decrease of more than 40 mmHg compared to baseline, or mBP < 65 mmHg) despite a fluid loading of 30 mL/kg (except if clinical or radiological sign of pulmonary fluid overload) requiring vasopressor infusion to maintain mBP > 65 mmHg
  • And lactate level > 2 mmol/L
  • Patient older than 18 years old affiliated to the French Social Security
  • Non-opposition of the patient (or of its next-of-kin) to participate in the study

Exclusion criteria

  • Ongoing dobutamine or epinephrine infusion
  • Severe left valvular disease (severe stenosis, severe regurgitation ≥ grade 3)
  • Constrictive pericarditis (invalidate the mitral tissue Doppler imaging)
  • Pregnant women
  • Patient with estimated life expectancy < 24h.

Treatment and study plan

Primary outcomes

  1. Survival

    Time frame: Day 28

    Survival at one month

Secondary outcomes

  1. Daily water balance

    Time frame: Day 1 to Day 3

    The daily water balance (from Day1 to Day3 included) will be measured

  2. Cumulated water balances

    Time frame: Day 4

    The cumulated water balance on Day4 (sum of water balances recorded from Day1 to Day3 included) will be calculated

Sponsors and collaborators

Lead sponsor

University Hospital, Limoges

Other

Collaborators

  • University Hospital, Tours

Registry information

Acronym: PRODIASYS2

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Sep 28, 2016
Registry last updated
Mar 19, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.